Researchers at Stanford have developed a porous biologics-loaded multimaterial construct, called Hybrid Tissue Engineering Construct (HyTEC), with applications in regenerative medicine and therapeutic delivery.
This invention is an innovative breakthrough in cancer radiotherapy, offering a cutting-edge solution to address the challenges of radio-resistant and immunosuppressive tumors.
Researchers at Stanford have found that a vaccine, enhanced with adjuvants that imprint an antiviral state on innate immune cells and non-hematopoietic organ cells, could confer lasting nonspecific protection against diverse pathogens.
Researchers at Stanford have developed methods to link antigenic or immunomodulatory molecules to bacterial surface proteins of commensal bacteria that result in a high immune response when applied to an epithelial surface of a mammal.
Stanford researchers have developed a scalable assay that combines single-molecule nucleic acid imaging with single-cell sequencing, enabling the enrichment and detailed study of rare cell populations in complex biological samples.
Stanford scientists have developed a method and apparatus for simultaneously measuring mucus rheology and cilia activity on live airway cells without removing mucus or inhibiting cilia function.
Stanford researchers have developed a highly specific, tunable system to improve the safety, efficacy and deliverability of gene therapy vectors and other biological therapies.
Immune checkpoint blockade, a class of immunotherapy treatment which works by blocking inhibitory receptors on T cells to improve immune responses, has proven to be a remarkable clinical advance in the treatment of many diseases, particularly in cancer.
Stanford scientists in Lacramioara Bintu's lab have developed a high-throughput system to identify regulatory domains in human RNA-binding proteins, presenting a new set of tools that could greatly enhance control over gene regulation at the RNA level for therapeutic and synth
Researchers at Stanford University have developed an affinity capture technique for top-down protein analysis that directly couples biolayer interferometry (BLI) with high resolution mass spectrometry (HR-MS).